CoChat

Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment

Open access
Martin, John D., Panagi, Myrofora, Wang, Chenyu, Khan, Thahomina T., Martin, Margaret R., Voutouri, Chrysovalantis, Toh, Kazuko, Papageorgis, Panagiotis, Mpekris, Fotios, Polydorou, Christiana, Ishii, Genichiro, Takahashi, Shinichiro, Gotohda, Naoto, Suzuki, Toshiyuki, Wilhelm, Matthew E., Melo, Vinicio Alejandro, Quader, Sabina, Norimatsu, Jumpei, Lanning, Ryan M., Kojima, Motohiro, Stuber, Matthew David, Stylianopoulos, Triantafyllos, Kataoka, Kazunori, Cabral, Horacio · 2019 · ACS Nano
Cited by 137

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Dexamethasone is a glucocorticoid steroid with anti-inflammatory properties used to treat many diseases, including cancer, in which it helps manage various side effects of chemo-, radio-, and immunotherapies. Here, we investigate the tumor microenvironment (TME)-normalizing effects of dexamethasone in metastatic murine breast cancer (BC). Dexamethasone normalizes vessels and the extracellular matrix, thereby reducing interstitial fluid pressure, tissue stiffness, and solid stress. In turn, the penetration of 13 and 32 nm dextrans, which represent nanocarriers (NCs), is increased. A mechanistic model of fluid and macromolecule transport in tumors predicts that dexamethasone increases NC penetration by increasing interstitial hydraulic conductivity without significantly reducing the effective pore diameter of the vessel wall. Also, dexamethasone increases the tumor accumulation and efficacy of ∼30 nm polymeric micelles containing cisplatin (CDDP/m) against murine models of primary BC and spontaneous BC lung metastasis, which also feature a TME with abnormal mechanical properties. These results suggest that pretreatment with dexamethasone before NC administration could increase efficacy against primary tumors and metastases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acsnano.8b07865

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 137

Metadata

Authors
Martin, J. D., Panagi, M., Wang, C., Khan, T. T., Martin, M. R., Voutouri, C., Toh, K., Papageorgis, P., Mpekris, F., Polydorou, C., Ishii, G., Takahashi, S., Gotohda, N., Suzuki, T., Wilhelm, M. E., Melo, V. A., Quader, S., Norimatsu, J., Lanning, R. M., Kojima, M., Stuber, M. D., Stylianopoulos, T., Kataoka, K., & Cabral, H.
Venue
ACS Nano
Published
2019-06-12
Volume
13
Issue
6
Pages
6396-6408
ISSN
  • 1936-0851 (ISSN-L)
  • 1936-086X
OpenAlex
W2949123718
Cited by
137
References
13
FWCI
5.31
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment. https://app.cochat.ai/papers/10.1021/acsnano.8b07865
The paper
Martin, J. D., Panagi, M., Wang, C., Khan, T. T., Martin, M. R., Voutouri, C., Toh, K., Papageorgis, P., Mpekris, F., Polydorou, C., Ishii, G., Takahashi, S., Gotohda, N., Suzuki, T., Wilhelm, M. E., Melo, V. A., Quader, S., Norimatsu, J., Lanning, R. M., . . . Cabral, H. (2019). Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment. ACS Nano. https://doi.org/10.1021/acsnano.8b07865

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.